JPRN-UMIN000023064尚未招募未知
To control antibody mediated rejection following kidney and liver transplantation in ABO-incompatible, donor specific antibody positive patients by using rituximab, proteasome inhibitor, complement inhibitor, and immunoglobulin administration - Management for antibody mediated rejection
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Cases who has allergic reaction against relevant drugs.
研究者
相似试验
尚未招募
不适用
Prevention of rejection after transplantation by donor-specific suppression immunity with donor exosomes (protocol id: DOBEX)liver grafts10019654rejectionNL-OMON41041Erasmus MC, Universitair Medisch Centrum Rotterdam40
招募中
2 期
Conversion of unresponsiveness to immunotherapy by Fecal Microbiota Transplantation in patients with metastatic melanoma and non-melanoma skin cancer: a randomized phase Ib/IIa trial10040900melanomaskin cancerNL-OMON52200Antoni van Leeuwenhoek Ziekenhuis28
进行中（未招募）
1 期
Effectivity of COVID-19 vaccination in people with Down syndromeEUCTR2021-002613-34-NLniversity Medical Center Utrecht640
招募中
4 期
Prospective monitoring of antibody response following COVID-19 vaccination in patients with Down syndromeNL-OMON54387niversitair Medisch Centrum Utrecht640
已完成
不适用
Sequential maintenance immunosuppression with mycophenolate and prednisolone: a randomised interventional trial in progressive immunoglobulin A nephritis (IgAN)Mesangioproliferative IgA glomerulonephritisUrological and Genital DiseasesNephritic syndromeISRCTN74038076niversitätsklinikum Ulm (Germany)70